6-[[5-chloro-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]amino]-1-cyclohexyl-3-ethoxyquinolin-2-one
C27H34ClN5O2 — CID 156729380
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[[5-chloro-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]amino]-1-cyclohexyl-3-ethoxyquinolin-2-one
6-[[5-chloro-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]amino]-1-cyclohexyl-3-ethoxyquinolin-2-one (PubChem CID 156729380) has the molecular formula C27H34ClN5O2 and a molecular weight of 496.06 g/mol. Its IUPAC name is 6-[[5-chloro-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]amino]-1-cyclohexyl-3-ethoxyquinolin-2-one.
Molecular Properties
| Compound Name | 6-[[5-chloro-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]amino]-1-cyclohexyl-3-ethoxyquinolin-2-one |
|---|---|
| PubChem CID | 156729380 |
| Molecular Formula | C27H34ClN5O2 |
| Molecular Weight | 496.06 g/mol |
| Exact Mass | 495.24 |
| IUPAC Name | 6-[[5-chloro-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]amino]-1-cyclohexyl-3-ethoxyquinolin-2-one |
| SMILES | CCOc1cc2cc(Nc3nc(N4CCCC(C)C4)ncc3Cl)ccc2n(C2CCCCC2)c1=O |
| InChI | InChI=1S/C27H34ClN5O2/c1-3-35-24-15-19-14-20(11-12-23(19)33(26(24)34)21-9-5-4-6-10-21)30-25-22(28)16-29-27(31-25)32-13-7-8-18(2)17-32/h11-12,14-16,18,21H,3-10,13,17H2,1-2H3,(H,29,30,31) |
| InChIKey | MZMXNMQTULJTGB-UHFFFAOYSA-N |
| XLogP | 6.33 |
| TPSA | 72.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 496.06 |
| LogP ≤ 5 | 6.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156729380 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.